-
Atyr PHARMA (NASDAQ:ATYR) Upgraded by Leerink Partnrs to "Strong-Buy" Rating
Source: Buzz FX / 19 Feb 2025 07:03:12 America/New_York
Atyr PHARMA (NASDAQ:ATYR) Upgraded by Leerink Partnrs to "Strong-Buy" Rating Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Atyr PHARMA ( NASDAQ:ATYR - Get Free Report ) was upgraded by research analysts at Leerink
Read more...